Figure 2
From: Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer

Survival of patients in whom more than 25% of the tumour cells stain for CD44v6 (VFF18) compared to those with less staining.
From: Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer
Survival of patients in whom more than 25% of the tumour cells stain for CD44v6 (VFF18) compared to those with less staining.